A collaboration between Parkwalk and Cambridge Enterprise
The University of Cambridge Enterprise Fund X is now open. Please email [email protected] or call 0207 062 9835 for more information.
The University of Cambridge Enterprise Funds (UCEF) invests in high-growth, IP-rich technologies founded at the University of Cambridge. By investing in UCEF, you can benefit from tax reliefs under the Enterprise Investment Scheme (EIS) outlined below, subject to personal tax circumstances.
5 EIS tax reliefs available:
- 30% Income tax relief, available in the year of investment or carried back to the previous year
- Capital gains tax deferral – on gains made in prior three years or for one year following investment
- IHT free – provided the investments are held for two years and are held at time of death
- Tax free capital gains on the investments
- Loss relief – option to claim losses against capital gains or income*
About The Fund
Launched in 2012, the University of Cambridge Enterprise Fund, managed by Parkwalk, offers University of Cambridge alumni and investors opportunities to invest into innovative, early-stage scientific and technological companies as they spin-out of the University of Cambridge. Our 10th UCEF, the Fund brings together the University’s research commercialisation arm – Cambridge Enterprise and Parkwalk, a leading technology EIS Fund Manager, to offer an early-stage, growth-targeted investment fund, with the potential to maximise tax-free capital gains.
*Please note: Investments must be held for 3 years to achieve all 5 tax reliefs. Tax reliefs are dependent upon an investor’s circumstances. We strongly suggest that you seek specialist tax advice. Tax benefits above are as at March 2024. Loss relief reduces the impact of a loss but does not eliminate it entirely.
Cambridge Enterprise Fund
Award winning Cambridge Enterprise, a wholly owned subsidiary of Cambridge University, champions world-changing innovation and seeks funding support for the University’s commercially viable discoveries. From patenting and licencing inventions to investment, Cambridge Enterprise has made a global impact from the commercialisation of University research. The University of Cambridge Enterprise Funds invest in companies selected by Cambridge Enterprise, providing a head start as they enter the initial stages of commercial product development.
The Fund utilises the tax reliefs of the government’s EIS and SEIS schemes where applicable.
Do not invest unless you are prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
Parkwalk Testimonals
University of Cambridge Enterprise Fund
Parkwalk
EIS Funds’ Valuations
Parkwalk is the largest growth EIS fund manager, focusing on a distinct asset class.
Our investment strategy yields fast deployment and a proven track record of delivering returns.
EIS Investing
Parkwalk makes full use of tax advantaged EIS qualifying investments enabling investors to benefit from government EIS tax reliefs. This balances risk and reward for investors, whilst financing innovative UK start-up companies and attracts a broad range of investors.
Risk Warning
The investments described in this website will place your capital at risk. Past performance may not be repeated and is not indicative of future results. Tax reliefs are dependent on investors’ individual circumstance and are subject to change. An investment in a fund managed by Parkwalk must be made only on the basis of the fund’s Information Memorandum and Key Information Document. Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such.
Parkwalk is the trading name of Parkwalk Advisors Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FRN: 502237). Parkwalk is registered in England & Wales (registration number 06925696) at 3 Pancras Square, King’s Cross N1C 4AG. Parkwalk is an IP Group plc company.
